2 ms·
Economists, and pharma lobbyists, argue against US drug price regulation because new drugs produce large positive externalities. I think it's a mix of pharma l
by 0xDEAFBEAD 2y ago
Economists, and pharma lobbyists, argue against US drug price regulation because new drugs produce large positive externalities.
I think it's a mix of pharma lobbying and also altruism. Pharma lobbies Congress to do the altruistic thing, and many Congresspeople agree, because they believe in markets and understand incentives.
- paulsutter 2y agoI’m arguing AGAINST the drug price regulation that allows pricing to be much higher in the US For example the prohibition on importing drugs from other countries, or the rules that prevent medicare from negotiating price for drugs